NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Shares Update on Corporate Activity
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a life-sciences holding company dedicated to building a portfolio of assets and biotech solutions, has provided updates on four key issues. The updates noted that FSD Pharma has appointed industry leaders Jason Sawyer and Dr. Ravinder Kumar to its advisory board and has been working to expand its team at all levels to synergize its operations; those efforts include appointing Dr. Andrzej Chruscinski as associate vice president of clinical affairs; Kevin Cassidy as vice president of quality systems; and Dr. Oksana Akhova as director, licensing, partnership and IP. In addition, FSD Pharma…







